FdaApplication
ANDA 216216
Identifiers
- fda_app_no: ANDA216216
Properties
| Property | Value |
|---|---|
| applicant_name | NE RX PHARMA LLC |
| application_type | ANDA |
| approval_date | 2022-10-25 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| METOLAZONE | METOLAZONE | 2.5MG | TABLET;ORAL |
| METOLAZONE | METOLAZONE | 5MG | TABLET;ORAL |
| METOLAZONE | METOLAZONE | 10MG | TABLET;ORAL |
3 products